McKinsey has now landed a new contract with the industry department for “professional advice supporting government objectives to establish onshore mRNA vaccine manufacturing”, running from 30 August to 20 December and worth $1.452 million.
It’s on top of a $2.2 million contract covering the first three months of this year to produce a business case for mRNA vaccine manufacturing, and a $2.1 million deal to support the approach to market process.
https://www.innovationaus.com/mckinsey-given-a-further-1-5m-by-government-for-mrna-vaccine-advice/
McKinsey has now landed a new contract with the industry...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.55M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $4.938K | 41.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 228269 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 36735 | 3 |
View Market Depth
| Last trade - 14.41pm 23/08/2024 (20 minute delay) ? |
| IDT (ASX) Chart |